General MedicationsORALStandard
FOSRENOL
LANTHANUM CARBONATE
Standard Dose
EQ 750MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview FOSRENOL is listed in Drugs@FDA under application 204734 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient LANTHANUM CARBONATE Form and strength POWDER;ORAL - EQ 750MG BASE Sponsor TAKEDA PHARMS USA Submission history Latest submission status date: 2024-08-29 00:00:00.
Structured Monograph
Clinical summary
Approval overview FOSRENOL is listed in Drugs@FDA under application 204734 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LANTHANUM CARBONATE Form and strength POWDER;ORAL - EQ 750MG BASE Sponsor TAKEDA PHARMS USA Submission history Latest submission status date: 2024-08-29 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.